Entero Healthcare Solutions' Statutory Auditor Converts from Firm to LLP Structure

Entero Healthcare Solutions has notified stock exchanges regarding a structural change in its statutory auditor. The company's auditing firm M S K A & Associates has converted itself into a Limited Liability Partnership (LLP) and is now operating as M S K A & Associates LLP, Chartered Accountants.

Conversion Details

The conversion took effect on January 13, 2026, under the provisions of the Limited Liability Partnership Act, 2008. The auditing firm communicated this change to Entero Healthcare Solutions through a letter dated January 14, 2026.

Parameter:	Details
Previous Name:	M S K A & Associates
New Name:	M S K A & Associates LLP
Effective Date:	January 13, 2026
ICAI Registration:	105047W/W101187
Legal Framework:	Limited Liability Partnership Act, 2008

Audit Engagement Continuity

Entero Healthcare Solutions has confirmed that the conversion does not impact the existing audit arrangement. M S K A & Associates LLP will continue to discharge their obligations as statutory auditors for the remaining tenure of their appointment. The audit engagement remains unchanged despite the structural transformation of the auditing firm.

Regulatory Compliance

The company has fulfilled its disclosure obligations under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Company Secretary and Compliance Officer Sanu Kapoor signed the intimation letter to both BSE and NSE on January 15, 2026.

The notification was sent to the Head of Listing Compliance Department at both stock exchanges, ensuring proper regulatory compliance and maintaining transparency with stakeholders regarding this administrative change in the company's statutory auditor structure.

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
-1.01%	+1.53%	+21.57%	-4.73%	-11.55%	+5.37%

SMALLCAP World Fund, Inc. has completely exited its position in Entero Healthcare Solutions Ltd through a substantial disposal of shares on December 29, 2025. The transaction, disclosed under SEBI's Regulation 29(2), represents a complete divestment of the fund's stake in the healthcare company.

Transaction Details

The disposal involved the complete sale of SMALLCAP World Fund's entire shareholding in Entero Healthcare Solutions. The fund sold all 2,277,083 shares it held, representing 5.24% of the company's total share capital.

Parameter:	Before Transaction	Transaction	After Transaction
Shares Held:	2,277,083	-2,277,083	0
Percentage Holding:	5.24%	-5.24%	0.00%
Transaction Method:	-	Open Market Sale	-

Share Capital Impact

The transaction occurred against the backdrop of changes in Entero Healthcare Solutions' share capital structure. The company's equity share capital increased from 43,493,767 shares before the transaction to 43,508,907 shares after the disposal, indicating concurrent corporate actions.

Metric:	Value
Pre-transaction Share Capital:	43,493,767 shares
Post-transaction Share Capital:	43,508,907 shares
Total Diluted Share Capital:	43,508,907 shares
ISIN Code:	INE010601016

Regulatory Compliance

The disclosure was made in accordance with Regulation 29(2) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. SMALLCAP World Fund confirmed it does not belong to the promoter or promoter group of Entero Healthcare Solutions.

The transaction was executed through net sales in the open market on December 29, 2025. The disclosure was signed by Luxman R. Nathan, Vice President, on behalf of Capital Research and Management Company, which serves as the investment adviser to SMALLCAP World Fund.

Market Presence

Entero Healthcare Solutions Ltd is listed on both the BSE and National Stock Exchange of India. The complete exit by SMALLCAP World Fund represents a significant change in the company's institutional shareholding pattern, with the fund reducing its stake from 5.24% to zero in a single transaction.